Previous 10 | Next 10 |
Deals and Financings Jiangsu Chia Tai Fenghai Pharma ((CTFH)) signed a $200-million agreement with Insilico Medicine, an AI drug discovery company headquartered in Hong Kong, to discover two triple-negative breast cancer candidates, aiming at previously undruggable targets. In September, I...
On the good news front in today's series, Stealth BioTherapeutics ( MITO ) and Alexion Pharmaceuticals ( ALXN ) have agreed to co-develop and commercialize elamipretide for mitochondrial diseases. Elamipretide, an inner mitochondrial membrane-targeting therapeutic, is Stealth BioTherapeutics...
Yandex (NASDAQ: YNDX ) -8% . More news on: Yandex N.V., OncoSec Medical Incorporated, Precipio, Inc., Stocks on the move, Read more ...
Gainers : Ra Pharmaceuticals, Inc. (NASDAQ: RARX ) +100% . OncoSec Medical Incorporated (NASDAQ: ONCS ) +34% . ProPetro Holding Corp. (NYSE: PUMP ) +22% . Mereo BioPharma Group plc (NASDAQ: MREO ) +21% . Bed Bath & Beyond (NASDAQ: BBBY ) +20% . Caladrius Biosciences (NASDAQ: CLBS ...
OncoSec Medical (NASDAQ: ONCS ) is up 34% premarket on entering into a strategic transaction with Grand Decade Developments Limited, a direct, wholly-owned subsidiary of China Grand Pharmaceutical and Healthcare Holdings, and its affiliate, Sirtex Medical US Holdings. Mo...
Ra Pharmaceuticals (NASDAQ: RARX ) +102% on being acquired by UCB SA. More news on: Ra Pharmaceuticals, Inc., OncoSec Medical Incorporated, Bed Bath & Beyond Inc., Stocks on the move, Read more ...
PENNINGTON, N.J. , Oct. 10, 2019 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (Nasdaq:ONCS), a late-stage intratumoral cancer immunotherapy company, today announced it entered into a strategic transaction with Grand Decade Developments Limited (Grand Decade), a direct, wholly-ow...
SAN DIEGO and PENNINGTON, N.J. , Sept. 26, 2019 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O'Connor , President and Chief Executive Officer of OncoSec, w...
SAN DIEGO and PENNINGTON, N.J. , Sept. 20, 2019 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O'Connor , President and Chief Executive Officer of OncoSec, w...
SAN DIEGO and PENNINGTON, N.J. , Sept. 6, 2019 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O'Connor , President and Chief Executive Officer of OncoSec, wi...
News, Short Squeeze, Breakout and More Instantly...
OncoSec Medical Incorporated Company Name:
ONCS Stock Symbol:
NASDAQ Market:
2023-06-25 06:00:00 ET 3 Tips for Investing in Penny Stocks in a Highly Volatile Market In the thrilling world of finance, penny stocks hold a unique place, providing investors with an affordable entry point and the potential for significant returns. As securities trading under $5 p...
2023-06-24 06:00:00 ET 3 Ways That Global Events Affect the Price of Penny Stocks The ever-changing global economic landscape inevitably impacts the financial markets, and penny stocks , defined as securities trading below $5 per share, are no exception. Particularly in 2023, these ...